Financhill
Back

Benitec Biopharma Quote, Financials, Valuation and Earnings

Benitec Biopharma Price Quote

$11.68
-0.09 (-5.43%)
(Updated: December 14, 2024 at 5:25 AM ET)

Benitec Biopharma Key Stats

Buy
58
Benitec Biopharma (BNTC) is a Buy

Day range:
$11.36 - $12.64
52-week range:
$2.69 - $13.22
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
4.26%

Volume:
52.1K
Avg. volume:
45.6K
1-year change:
255.59%
Market cap:
$273.3M
Revenue:
$0
EPS:
$-5.29

How Much Does Benitec Biopharma Make?

Data Unavailable

Is Benitec Biopharma Growing As A Company?

Data Unavailable

Benitec Biopharma Stock Price Performance

What Is Benitec Biopharma 52-Week High & Low?

Benitec Biopharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Benitec Biopharma?

  • How Much Debt Does Benitec Biopharma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Benitec Biopharma Have?
    Cash and short term investments quarterly total is $67.8M
  • What Is Benitec Biopharma’s Book Value Per Share?
    Book value per share is 3.59

Is Benitec Biopharma Cash Flow Positive?

  • What Is BNTC Cash Flow From Operations?
    Cash flow from operations (TTM) is -$19.4M
  • What Is Benitec Biopharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $61.8M
  • What Is Benitec Biopharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$179K

Benitec Biopharma Return On Invested Capital

Data Unavailable

Benitec Biopharma Earnings Date & Stock Price

Benitec Biopharma Competitors

  • Who Are Benitec Biopharma's Competitors?
    Below is a list of companies who compete with Benitec Biopharma or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Oragenics Inc (OGEN)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Benitec Biopharma Dividend Yield

Benitec Biopharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 24.74
Upside from Last Price: 110.19%

Major Shareholders

  • How many BNTC shares are owned by institutional investors?
    19.6M BNTC shares are owned by institutional investors
  • How many BNTC shares are owned by insiders?
    78.3K BNTC shares are owned by insiders